- The trend backdrop is active with a 25-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is constructive, supporting the smart-money activity read.
MPE
LSE
Week ended 07 Aug 2026
Weekly Investor Report
M.P. Evans Group PLC · Consumer Defensive · Farm Products
Latest close
1,676 GBP
3.1%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 8.3% above the Trend Line and sits at 68.1% of its 52-week range. The latest completed week returned 3.1%, after a 5.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 56/100. Near-term considerations: volume confirmation is below normal.
Setup score
57
out of 100
Latest Close
1,676 GBP
7 Aug 2026
1W Return
3.1%
latest completed week
4W Return
5.3%
short-term follow-through
12W Return
-10.2%
quarterly tape
Trend Breadth
82.7%
43 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.1%
Latest completed week; four-week move 5.3%.
Indicator stack
90/49
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
56/100
16 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 8.3% above the Trend Line and sits at 68.1% of its 52-week range. The latest completed week returned 3.1%, after a 5.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6012-week average 0.71
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.60Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 5.3% over four weeks, -10.2% over 12 weeks, and 25.6% over one year. The current trend has remained active for 25 consecutive weeks.
Performance by holding period
Active trend streak25 weeks
Active weeks in one year43
Trend breadth82.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.32Latest activity-pressure read.
Pressure change59.2%Four-week change in activity pressure.
Leadership7.69Latest relative-leadership reading.
RS change11.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 88%
Model confidence 70%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength99/100Blend of value, momentum, and quality. Underlying universe rank 2; rank 1 is best.
Value97/100Relative valuation strength. Underlying universe rank 4; rank 1 is best.
Quality93/100Profitability and accounting quality. Underlying universe rank 8; rank 1 is best.
Momentum89/100Medium-term price momentum. Underlying universe rank 12; rank 1 is best.
Growth85/100Revenue and earnings growth. Underlying universe rank 16; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework92/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 7.8x Price divided by trailing earnings.
- Price / sales
- 2.3x Market value relative to trailing revenue.
- EV / EBITDA
- 4.7x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 14.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 38.3% Gross profit retained from each unit of revenue.
- Operating margin
- 37.1% Operating profit retained from revenue.
- Free-cash-flow margin
- 30.3% Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 5.1% Latest one-year revenue growth.
- EPS growth
- 29.2% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -1.5% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 8/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 3.6% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 3.6% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.5x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment56/100
Weighted news tone is neutral across 16 relevant articles.
5 positive · 11 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-12.6%Distance below the 52-week high.
13-week volatility6.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+16.9%Week of 13 Feb.
Worst week-18.3%Week of 22 May.
Latest week+3.1%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains7
Flat weeks0
Modest losses8
Sharp losses3
Recent vol6.3%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split26/24Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Consumer Defensive
4-week rank19 / 58
Group average3.2%
Trend breadth44.8%
Trend44.8%active weekly trend signals
MD62.1%positive activity pressure
RS29.3%positive relative leadership
Four-week leaders
IndustryGB Farm Products
4-week rank1 / 6
Group average0.2%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD0.0%positive activity pressure
RS33.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape60/100
Trend, activity pressure, participation, and risk combine to a 60/100 tape read.
Indicator analysis67/100Latest 12-week confirmation: trend 12/12, activity pressure 3/12, relative leadership 11/12.
Activity pressure 0.60; No reversal markers Factors94/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 77; Small Cap Core rank 24 SVQF92/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 23.0 of 260 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment56/100Weighted news tone is neutral across 16 relevant articles.
M.P. Evans Group Finalizes Share Buyback, Acquiring 2,941 Shares at 1,673.46 Pence Average Price Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,676 GBP | 3.1% | 1,548 GBP | 1,079 GBP | -0.32 | 7.69 | 310.7K | On |
| 31 Jul 2026 | 1,626 GBP | -5.5% | 1,533 GBP | 1,073 GBP | -0.35 | 4.89 | 578.0K | On |
| 24 Jul 2026 | 1,720 GBP | 4.2% | 1,520 GBP | 1,067 GBP | -0.46 | 12.40 | 758.4K | On |
| 17 Jul 2026 | 1,650 GBP | 3.6% | 1,502 GBP | 1,061 GBP | -0.68 | 9.50 | 413.3K | On |
| 10 Jul 2026 | 1,592 GBP | 5.7% | 1,487 GBP | 1,054 GBP | -0.79 | 6.92 | 430.6K | On |
| 3 Jul 2026 | 1,506 GBP | -0.9% | 1,476 GBP | 1,049 GBP | -0.84 | -0.36 | 33.3K | On |
| 26 Jun 2026 | 1,520 GBP | -1.6% | 1,469 GBP | 1,043 GBP | -0.83 | 2.32 | 32.9K | On |
| 19 Jun 2026 | 1,544 GBP | -1.4% | 1,461 GBP | 1,038 GBP | -0.66 | 5.68 | 39.4K | On |
| 12 Jun 2026 | 1,566 GBP | 5.7% | 1,452 GBP | 1,033 GBP | -0.31 | 6.40 | 285.9K | On |
| 5 Jun 2026 | 1,482 GBP | -3.6% | 1,444 GBP | 1,028 GBP | 0.27 | 2.06 | 82.9K | On |
| 29 May 2026 | 1,538 GBP | 0.9% | 1,437 GBP | 1,023 GBP | 0.92 | 5.88 | 767.4K | On |
| 22 May 2026 | 1,524 GBP | -18.3% | 1,431 GBP | 1,018 GBP | 1.37 | 4.76 | 1.9M | On |
| 15 May 2026 | 1,866 GBP | 4.6% | 1,423 GBP | 1,013 GBP | 1.63 | 32.12 | 382.7K | On |
| 8 May 2026 | 1,784 GBP | -1.1% | 1,403 GBP | 1,007 GBP | 1.61 | 26.91 | 722.6K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.